These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7995957)

  • 21. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
    Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
    Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
    Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
    Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
    Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
    J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 env-specific cellular cytotoxicity in HIV-1-seropositive mothers and their infants.
    Skowron G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S79-82. PubMed ID: 7865338
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
    Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.
    Kent SJ; Corey L; Agy MB; Morton WR; McElrath MJ; Greenberg PD
    J Clin Invest; 1995 Jan; 95(1):248-56. PubMed ID: 7814622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection.
    Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F
    J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection.
    Ibarrondo FJ; Anton PA; Fuerst M; Ng HL; Wong JT; Matud J; Elliott J; Shih R; Hausner MA; Price C; Hultin LE; Hultin PM; Jamieson BD; Yang OO
    J Virol; 2005 Apr; 79(7):4289-97. PubMed ID: 15767429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.
    Pikora CA; Sullivan JL; Panicali D; Luzuriaga K
    J Exp Med; 1997 Apr; 185(7):1153-61. PubMed ID: 9104802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
    McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
    J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants.
    Nazziwa J; Andrews SM; Hou MM; Bruhn CAW; Garcia-Knight MA; Slyker J; Hill S; Lohman Payne B; Moringas D; Lemey P; John-Stewart G; Rowland-Jones SL; Esbjörnsson J
    J Virol; 2024 Jul; 98(7):e0007224. PubMed ID: 38814066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators.
    Jin X; Roberts CG; Nixon DF; Cao Y; Ho DD; Walker BD; Muldoon M; Korber BT; Koup RA
    J Infect Dis; 1998 Nov; 178(5):1317-26. PubMed ID: 9780251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
    Aladdin H; Ullum H; Lepri AC; Leffers H; Katzenstein T; Gerstoft J; Gjedde SB; Phillips AN; Skinhøj P; Pedersen BK
    Scand J Immunol; 1999 Aug; 50(2):223-7. PubMed ID: 10447929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.
    Nixon DF; Douek D; Kuebler PJ; Jin X; Vesanen M; Bonhoeffer S; Cao Y; Koup RA; Ho DD; Markowitz M
    Immunol Lett; 1999 Mar; 66(1-3):219-28. PubMed ID: 10203058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection.
    Garcia-Knight MA; Slyker J; Payne BL; Pond SL; de Silva TI; Chohan B; Khasimwa B; Mbori-Ngacha D; John-Stewart G; Rowland-Jones SL; Esbjörnsson J
    Sci Rep; 2016 Jul; 6():29536. PubMed ID: 27403940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.
    Dyer WB; Ogg GS; Demoitie MA; Jin X; Geczy AF; Rowland-Jones SL; McMichael AJ; Nixon DF; Sullivan JS
    J Virol; 1999 Jan; 73(1):436-43. PubMed ID: 9847349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV.
    Rivière Y; Buseyne F
    Vaccine; 1998; 16(14-15):1420-2. PubMed ID: 9711782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection.
    Luzuriaga K; McQuilken P; Alimenti A; Somasundaran M; Hesselton R; Sullivan JL
    J Infect Dis; 1993 May; 167(5):1008-13. PubMed ID: 8486935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission.
    Kuhn L; Coutsoudis A; Moodley D; Trabattoni D; Mngqundaniso N; Shearer GM; Clerici M; Coovadia HM; Stein Z
    AIDS; 2001 Jan; 15(1):1-9. PubMed ID: 11192849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.